Tumor location | Parameters | Median survival (days) | Univariate analysis P (log rank) |
---|---|---|---|
220 Ph cancers | Age (< 65/ ≥65 years) | 499/480 | 0.131 |
Gender (male/female) | 454/615 | 0.335 | |
Tumor size (< 3/ ≥3 cm) | 555/488 | 0.358 | |
Well/Moderate/poor Differentiation | 615/555/411 | 0.155 | |
T stage (T1 + T2/T3) | 488/454 | 0.105 | |
Lymph nodes metastasis (N0/N1/N2) | 565/418/185 | 0.004 | |
8th AJCC stage (I + II /III + IV) | 360/273 | 0.017 | |
Perineural invasion (absent/present) | 880/545 | 0.298 | |
Vascular permeation (absent/present) | 565/350 | 0.005 | |
CA19–9 level (< 37 U/ml/ ≥37 U/ml) | 666/450 | 0.171 | |
PLM | |||
absent/present | 586/365 | 0.039 | |
131 Pbt cancers | Age (< 65/ ≥65 years) | 381/300 | 0.111 |
Gender (male/female) | 395/340 | 0.439 | |
Tumor size (< 3/ ≥3 cm) | 530/320 | 0.023 | |
Well/Moderate/poor Differentiation | 400/280/273 | 0.070 | |
T stage (T1 + T2/ T3 + T4) | 418/320 | 0.016 | |
Lymph nodes metastasis (N0/N1/N2) | 360/259/234 | 0.007 | |
8th AJCC stage (I + II /III + IV) | 499/273 | 0.001 | |
Perineural invasion (absent/present) | 360/333 | 0.104 | |
Vascular permeation (absent/present) | 400/265 | 0.009 | |
CA19–9 level (< 37 U/ml/ ≥37 U/ml) | 468/331 | 0.099 | |
PLM | 432/275 | 0.001 | |
absent/present |